CN101062302A - Chinese medicinal preparation for hepatitis B - Google Patents
Chinese medicinal preparation for hepatitis B Download PDFInfo
- Publication number
- CN101062302A CN101062302A CNA2007100158621A CN200710015862A CN101062302A CN 101062302 A CN101062302 A CN 101062302A CN A2007100158621 A CNA2007100158621 A CN A2007100158621A CN 200710015862 A CN200710015862 A CN 200710015862A CN 101062302 A CN101062302 A CN 101062302A
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- hepatitis
- chinese medicinal
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese preparation for treating hepatitis B which comprises the following raw materials (by weight portion): astragalus root 15-20, radix salvia miltiorrhiza 15-20, root bark of tree peony 10-15, alkanna tinctoria 10-15, oriental wormwood 15-20, cape jasmine 15-20, root of pilose asiabell 12-16, white atractylodes rhizome 12-16,and oldenlandia 15-20, radix isatidis 15-20, large-leaf gentian root 10-15, Loranthus mulberry mistletoe 12-16, Achyranthes bidentatae 10-15, poria cocos wolf 12-16, eclipta 12-16, cogongrass rhizome 15-20 and turtle shell 15-20.
Description
Technical field
The present invention relates to a kind of Chinese medicinal formulae for the treatment of hepatitis B in the field of traditional Chinese.
Background technology
The treatment of hepatitis B at present has Western medicine and treatment by Chinese herbs, and the Western medicine side effect is big, the repeatability height; Chinese medicine is many with clearing away heat and eliminating dampness detoxifcation configuration medicine, and curative effect is good inadequately.The basic pathogenesis of hepatitis B is deficient vital QI leading to lingering of pathogen, and evil poison is at blood.Behind the infective virus, the dark volt of evil poison blood system shows as damp and hot characteristic, thereby makes the touching difficulty of primary disease more.But with the passing of time damp and hot malicious heresy not only impairment of YANG but also energy loss the moon can cause cloudy blood yang-energy damage, and the positive deficiency of vital energy declines, and disease-resistant repair ability weakens, and its disease is difficult more.This onset of disease gradually causes wood and takes advantage of spleen soil or hepatopathy and kidney liver, or liver,spleen,kidney three is dirty with sick.Heresy must cause the QI-blood circulation imbalance at blood system, presents the qi depression to blood stasis state.
Summary of the invention
Purpose of the present invention is exactly the defective that exists at prior art, and a kind of Chinese medicinal formulae of taking the treatment hepatitis B of synthesis treatments such as clearing away heat and eliminating dampness detoxifcation, nourishing kidney spleen invigorating easing the affected liver, promoting flow of QI and blood in treatment is provided.
Its technical scheme is that the raw material that comprises following weight portion is formed: Radix Astragali 15-20, Radix Salviae Miltiorrhizae 15-20, Cortex Moutan 10-15, Radix Arnebiae (Radix Lithospermi) 10-15, Herba Artemisiae Scopariae 15-20, Fructus Gardeniae 15-20, Radix Codonopsis 12-16, Rhizoma Atractylodis Macrocephalae 12-16, Herba Hedyotidis Diffusae 15-20, Radix Isatidis 15-20, Radix Gentianae Macrophyllae 10-15, Herba Taxilli 12-16, Radix Achyranthis Bidentatae 10-15, Poria 12-16, Herba Ecliptae 12-16, Rhizoma Imperatae 15-20, Carapax Trionycis (processed) 15-20.
The raw material that also comprises following weight portion in the such scheme is formed: Fructus Ligustri Lucidi 10-15, Cortex Albiziae 15-20, Caulis Polygoni Multiflori 10-15.
The present invention has the air making-up and spleen enlivening nourishing kidney, clearing away heat and eliminating dampness antidotal effect.We detoxify with Herba Artemisiae Scopariae, Radix Isatidis, Herba Hedyotidis Diffusae removing damp-heat, join Fructus Gardeniae, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Rhizoma Imperatae, Radix Salviae Miltiorrhizae removing pathogenic heat from blood and toxic substance from the body, blood circulation promoting and blood stasis dispelling, the Radix Gentianae Macrophyllae expelling wind and dampness, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Codonopsis, Poria air making-up and spleen enlivening, Carapax Trionycis, Herba Taxilli, Radix Achyranthis Bidentatae, Herba Ecliptae enriching yin and nourishing kidney are with the mother of the liver benefiting.Comprehensive all medicines are set upright with eliminating evil and same, regulate the flow of vital energy and invigorate blood circulation with executing, liver,spleen,kidney three is dirty and transfer, can the clearing away heat and eliminating dampness detoxifcation suppressing or to remove hepatitis B virus, but strengthening the body resistance and regulate immunologic function again, can also improve the liver blood circulation by blood circulation promoting and blood stasis dispelling, to reach the purpose of synthesis treatment.In treatment hepatitis overall process, have QI invigorating and body resistance strengthening human body immunity improving function, under the not heavy situation of the evil performance of damp and hot poison, can suitably reuse air making-up and spleen enlivening kidney tonifying medicine, to set upright blood stasis dispelling; Mediation Liver Channel QI and blood is to recover the liver normal physiological function.
The specific embodiment
Embodiment 1: Radix Astragali 15g, Radix Salviae Miltiorrhizae 15g, Cortex Moutan 10g, Radix Arnebiae (Radix Lithospermi) 10g, Herba Artemisiae Scopariae 15g, Fructus Gardeniae 15g, Radix Codonopsis 12g, Rhizoma Atractylodis Macrocephalae 12g, Herba Hedyotidis Diffusae 15g, Radix Isatidis 15g, Radix Gentianae Macrophyllae 10g, Herba Taxilli 12g, Radix Achyranthis Bidentatae 10g, Poria 12g, Herba Ecliptae 12g, Rhizoma Imperatae 15g, Carapax Trionycis (processed) 15g.
Embodiment 2: Radix Astragali 15g, Radix Salviae Miltiorrhizae 15g, Cortex Moutan 10g, Radix Arnebiae (Radix Lithospermi) 10g, Herba Artemisiae Scopariae 15g, Fructus Gardeniae 15g, Radix Codonopsis 12g, Rhizoma Atractylodis Macrocephalae 12g, Herba Hedyotidis Diffusae 15g, Radix Isatidis 15g, Radix Gentianae Macrophyllae 10g, Herba Taxilli 12g, Radix Achyranthis Bidentatae 10g, Poria 12g, Herba Ecliptae 12g, Rhizoma Imperatae 15g, Carapax Trionycis (processed) 15g, Fructus Ligustri Lucidi 10g, Cortex Albiziae 15g, Caulis Polygoni Multiflori 12g.
Adopt above-mentioned prescription, can utilize existing process equipment processing and fabricating powder to take after mixing it with water, pill or tablet are oral or the like.
Claims (2)
1, a kind of Chinese medicinal formulae for the treatment of hepatitis B is characterized in that comprising that the raw material of following weight portion is formed:
Radix Astragali 15-20, Radix Salviae Miltiorrhizae 15-20, Cortex Moutan 10-15, Radix Arnebiae (Radix Lithospermi) 10-15, Herba Artemisiae Scopariae 15-20, Fructus Gardeniae 15-20, Radix Codonopsis 12-16, Rhizoma Atractylodis Macrocephalae 12-16, Herba Hedyotidis Diffusae 15-20, Radix Isatidis 15-20, Radix Gentianae Macrophyllae 10-15, Herba Taxilli 12-16, Radix Achyranthis Bidentatae 10-15, Poria 12-16, Herba Ecliptae 12-16, Rhizoma Imperatae 15-20, Carapax Trionycis (processed) 15-20.
2, the Chinese medicinal formulae of treatment hepatitis B according to claim 1 is characterized in that also comprising that the raw material of following weight portion is formed: Fructus Ligustri Lucidi 10-15, Cortex Albiziae 15-20, Caulis Polygoni Multiflori 10-15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100158621A CN101062302A (en) | 2007-06-07 | 2007-06-07 | Chinese medicinal preparation for hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100158621A CN101062302A (en) | 2007-06-07 | 2007-06-07 | Chinese medicinal preparation for hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101062302A true CN101062302A (en) | 2007-10-31 |
Family
ID=38963719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100158621A Pending CN101062302A (en) | 2007-06-07 | 2007-06-07 | Chinese medicinal preparation for hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101062302A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2502629A1 (en) * | 2009-11-16 | 2012-09-26 | Jong Hyun Nam | Liver function enhancer composition |
| CN105079578A (en) * | 2015-09-23 | 2015-11-25 | 黄名珠 | Medicine for treating hepatitis B |
-
2007
- 2007-06-07 CN CNA2007100158621A patent/CN101062302A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2502629A1 (en) * | 2009-11-16 | 2012-09-26 | Jong Hyun Nam | Liver function enhancer composition |
| EP2502629A4 (en) * | 2009-11-16 | 2014-12-17 | Jong Hyun Nam | Liver function enhancer composition |
| CN105079578A (en) * | 2015-09-23 | 2015-11-25 | 黄名珠 | Medicine for treating hepatitis B |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1279073A (en) | Antisenility Chinese medicine | |
| CN101455791A (en) | Pure traditional Chinese medicine preparation for treating hyperlipemia | |
| CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
| CN100400094C (en) | Traditional Chinese medicine for treating hepatitis B and its preparing process | |
| CN1245707A (en) | Chinese medicine for curing AIDS and carcinomatosis | |
| CN110960619A (en) | Traditional Chinese medicine composition for treating African swine fever | |
| CN101152539A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
| CN101745092A (en) | Traditional Chinese medicine for treating infantile diarrhea | |
| CN101284113A (en) | Yin toxin Qingyuan pellet | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN1052884C (en) | Traditional Chinese medicine Baiyuwan pill for treating vitiligo | |
| CN1218706C (en) | Hepatitis B treaitng pill | |
| CN100534506C (en) | Chinese medicinal mixture for treating viral hepatitis | |
| CN1140291C (en) | Stone-eliminating Jinyin medicine powder | |
| CN101062302A (en) | Chinese medicinal preparation for hepatitis B | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN101167969A (en) | Traditional Chinese medicine for treating meniere's syndrome | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN102423441A (en) | Double-formula medicine used for treating constipation, and preparation method thereof | |
| CN1058622C (en) | Rehabilitation powder for hepatitis B | |
| CN103800859A (en) | Traditional Chinese medicinal composition for treating stomach cold | |
| CN101837114A (en) | Medicinal composition for treating palpitation | |
| CN1086141C (en) | Medicine for treating early-stage hepatocirrhosis and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071031 |